FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

5429311000001108: Ondansetron 4mg tablets 15 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22947101000001118 Ondansetron 4mg tablets 15 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22947201000001113 Ondansetron 4mg tablets 15 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 4mg tablets 15 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet Is pack of Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet Has active ingredient Ondansetron hydrochloride false Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet Has active ingredient Ondansetron false Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet Has VMP Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet Has specific active ingredient Ondansetron hydrochloride true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets 15 tablet Has basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zofran 4mg tablets (PI) (Dowelhurst Ltd) 15 tablet 3 x 5 tablets Is a True Ondansetron 4mg tablets 15 tablet Inferred relationship Existential restriction modifier
Zofran 4mg tablets (PI) (Waymade Ltd) 15 tablet 3 x 5 tablets Is a True Ondansetron 4mg tablets 15 tablet Inferred relationship Existential restriction modifier
Zofran 4mg tablets (Sigma Pharmaceuticals Plc) 15 tablet Is a True Ondansetron 4mg tablets 15 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start